Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies

Background— The aim of this study was to estimate the impact of thrombophilia on risk of first childhood stroke through a meta-analysis of published observational studies. Methods and Results— A systematic search of electronic databases (Medline via PubMed, EMBASE, OVID, Web of Science, The Cochrane Library) for studies published from 1970 to 2009 was conducted. Data on year of publication, study design, country of origin, number of patients/control subjects, ethnicity, stroke type (arterial ischemic stroke [AIS], cerebral venous sinus thrombosis [CSVT]) were abstracted. Publication bias indicator and heterogeneity across studies were evaluated, and summary odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with fixed-effects or random-effects models. Twenty-two of 185 references met inclusion criteria. Thus, 1764 patients (arterial ischemic stroke [AIS], 1526; cerebral sinus venous thrombosis [CSVT], 238) and 2799 control subjects (neonate to 18 years of age) were enrolled. No significant heterogeneity was discerned across studies, and no publication bias was detected. A statistically significant association with first stroke was demonstrated for each thrombophilia trait evaluated, with no difference found between AIS and CSVT. Summary ORs (fixed-effects model) were as follows: antithrombin deficiency, 7.06 (95% CI, 2.44 to 22.42); protein C deficiency, 8.76 (95% CI, 4.53 to 16.96); protein S deficiency, 3.20 (95% CI, 1.22 to 8.40), factor V G1691A, 3.26 (95% CI, 2.59 to 4.10); factor II G20210A, 2.43 (95% CI, 1.67 to 3.51); MTHFR C677T (AIS), 1.58 (95% CI, 1.20 to 2.08); antiphospholipid antibodies (AIS), 6.95 (95% CI, 3.67 to 13.14); elevated lipoprotein(a), 6.27 (95% CI, 4.52 to 8.69), and combined thrombophilias, 11.86 (95% CI, 5.93 to 23.73). In the 6 exclusively perinatal AIS studies, summary ORs were as follows: factor V, 3.56 (95% CI, 2.29 to 5.53); and factor II, 2.02 (95% CI, 1.02 to 3.99). Conclusions— The present meta-analysis indicates that thrombophilias serve as risk factors for incident stroke. However, the impact of thrombophilias on outcome and recurrence risk needs to be further investigated.

[1]  Stephen Kaptoge,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[2]  M. Ruggieri,et al.  Stroke in children: inherited and acquired factors and age‐related variations in the presentation of 48 paediatric patients , 2009, Acta paediatrica.

[3]  M. Stoll,et al.  Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: a family-based cohort study. , 2009, Blood.

[4]  E. Schiff,et al.  Factor V Leiden and Antiphospholipid Antibodies in Either Mothers or Infants Increase the Risk for Perinatal Arterial Ischemic Stroke , 2009, Stroke.

[5]  M. Stoll,et al.  Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies. , 2008, Blood.

[6]  P. Monagle,et al.  Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies , 2008, Circulation.

[7]  M. Stoll,et al.  Genetics of Hemostasis: Differential Effects of Heritability and Household Components Influencing Lipid Concentrations and Clotting Factor Levels in 282 Pediatric Stroke Families , 2008, Environmental health perspectives.

[8]  A. Suppiej,et al.  Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. , 2008, Thrombosis research.

[9]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[10]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.

[11]  E. Roeder,et al.  Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. , 2007, Pediatric neurology.

[12]  F. Sofi,et al.  Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. , 2007, The American journal of medicine.

[13]  J. Dietrich,et al.  Efficacy of family history in determining thrombophilia risk. , 2007, Journal of pediatric and adolescent gynecology.

[14]  F. Kirkham,et al.  Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study , 2007, The Lancet Neurology.

[15]  V. Thijs,et al.  Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies , 2007, Stroke.

[16]  S. Aysun,et al.  Significance of Factor V, Prothrombin, MTHFR, and PAI-1 Genotypes in Childhood Cerebral Thrombosis , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[17]  H. Platokouki,et al.  Mutations and Polymorphisms in Genes Affecting Haemostasis Components in Children with Thromboembolic Events , 2007, Pathophysiology of Haemostasis and Thrombosis.

[18]  S. Revel-Vilk,et al.  Antiphospholipid syndrome and recurrent thrombosis in children. , 2006, Arthritis and rheumatism.

[19]  A. Wade,et al.  Clinical and Radiological Recurrence After Childhood Arterial Ischemic Stroke , 2006, Circulation.

[20]  Steven P. Miller,et al.  Candidate Gene Polymorphisms Do Not Differ Between Newborns With Stroke and Normal Controls , 2006, Stroke.

[21]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[22]  P. Simioni,et al.  Thrombosis and thrombophilia in children: a systematic review. , 2006, Seminars in thrombosis and hemostasis.

[23]  L. Iacoviello,et al.  Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. , 2006, Blood.

[24]  J. Broderick,et al.  Temporal Trends in the Incidence and Case Fatality of Stroke in Children and Adolescents , 2006, Journal of child neurology.

[25]  H. Platokouki,et al.  Mutations and Polymorphisms in Genes Affecting Hemostasis Proteins and Homocysteine Metabolism in Children with Arterial Ischemic Stroke , 2006, Cerebrovascular Diseases.

[26]  M. Bonduel,et al.  Arterial Ischemic Stroke and Cerebral Venous Thrombosis in Children: A 12-Year Argentinean Registry , 2006, Acta Haematologica.

[27]  L. Williams,et al.  Family history is a poor screen for prothrombotic genes in children with stroke. , 2006, The Journal of pediatrics.

[28]  K. Nelson,et al.  Prothrombotic Factors in Children With Stroke or Porencephaly , 2005, Pediatrics.

[29]  E. Chalmers.  Perinatal stroke – risk factors and management , 2005, British journal of haematology.

[30]  A. Sturm,et al.  Homocysteine and MTHFR Mutations Relation to Thrombosis and Coronary Artery Disease , 2005 .

[31]  V. Ganesan,et al.  Thrombophilia and first arterial ischaemic stroke: a systematic review , 2005, Archives of Disease in Childhood.

[32]  A. Wade,et al.  Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. , 2005, Brain : a journal of neurology.

[33]  D. Ferriero,et al.  Maternal and infant characteristics associated with perinatal arterial stroke in the infant. , 2005, JAMA.

[34]  S. Karasalihoǧlu,et al.  Factor V Leiden Mutation and Other Thrombophilia Markers in Childhood Ischemic Stroke , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[35]  F. Wesenberg,et al.  DIAGNOSTIC VALUE OF FAMILY HISTORIES OF THROMBOSIS TO IDENTIFY CHILDREN WITH THROMBOPHILIA , 2005, Pediatric hematology and oncology.

[36]  B. Anlar,et al.  Role of protein C in childhood cerebrovascular occlusive accidents , 1989, European Journal of Pediatrics.

[37]  A. Toren,et al.  Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. , 2004, Thrombosis and haemostasis.

[38]  F. Gumruk,et al.  Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[39]  R. Rossi,et al.  The factor V G1691A mutation is a risk for porencephaly: A case–control study , 2004, Annals of neurology.

[40]  Kevork Hopayian,et al.  Essential Evidence-based Medicine , 2005, ACP Journal Club.

[41]  Brian Chung,et al.  Pediatric stroke among Hong Kong Chinese subjects. , 2004, Pediatrics.

[42]  A. Harvey,et al.  Thrombophilia interpretation in childhood stroke: a cautionary tale. , 2004, Journal of Child Neurology.

[43]  A. Heinecke,et al.  Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children , 2003, Thrombosis and Haemostasis.

[44]  K. Kurnik,et al.  Recurrent Thromboembolism in Infants and Children Suffering From Symptomatic Neonatal Arterial Stroke: A Prospective Follow-Up Study , 2003, Stroke.

[45]  A. von Eckardstein,et al.  Cerebral Venous Thrombosis in Children: A Multifactorial Origin , 2003, Circulation.

[46]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[47]  M. Golomb.  The Contribution of Prothrombotic Disorders to Peri- and Neonatal Ischemic Stroke , 2003, Seminars in thrombosis and hemostasis.

[48]  M. Boffa,et al.  Inhibition of Plasminogen Activation by Lipoprotein(a) , 2003, Journal of Biological Chemistry.

[49]  M. Bonduel,et al.  Factor V leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism , 2003, American journal of hematology.

[50]  J. Gill,et al.  Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study , 2003, Journal of thrombosis and haemostasis : JTH.

[51]  A. Wade,et al.  Investigation of risk factors in children with arterial ischemic stroke , 2003, Annals of neurology.

[52]  P. Maciel,et al.  Inherited and acquired risk factors and their combined effects in pediatric stroke. , 2003, Pediatric neurology.

[53]  E. Chalmers,et al.  The investigation and management of neonatal haemostasis and thrombosis * , 2002, British journal of haematology.

[54]  P. Prandoni,et al.  The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. , 2002, Blood.

[55]  E. Neufeld,et al.  Risk factors for thromboembolism in teens: when should I test? , 2002, Current opinion in pediatrics.

[56]  M. Bonduel,et al.  Factor V Leiden and Prothrombin Gene G20210A Mutation in Children with Venous Thromboembolism , 2002, Thrombosis and Haemostasis.

[57]  D. Hirtz,et al.  Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. , 2002, Pediatrics.

[58]  K. Nelson,et al.  Epidemiology of perinatal stroke , 2001, Current opinion in pediatrics.

[59]  C. Camfield,et al.  Cerebral sinovenous thrombosis in children. , 2001, The New England journal of medicine.

[60]  B. McCrindle,et al.  Presumed pre‐ or perinatal arterial ischemic stroke: Risk factors and outcomes , 2001, Annals of neurology.

[61]  E. Mercuri,et al.  Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. , 2001, Pediatrics.

[62]  N. Akar,et al.  Common mutations at the homocysteine metabolism pathway and pediatric stroke. , 2001, Thrombosis research.

[63]  F. Kirkham,et al.  Homozygous thermolabile variant of the methylenetetrahy‐drofolate reductase gene: a potential risk factor for hyperhomo‐cysteinaemia, CVD, and stroke in childhood , 2001, Developmental medicine and child neurology.

[64]  R. Junker,et al.  Symptomatic Ischemic Stroke in Full-Term Neonates: Role of Acquired and Genetic Prothrombotic Risk Factors , 2000, Stroke.

[65]  G. Rechavi,et al.  Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. , 2000, Stroke.

[66]  E. Monrós,et al.  Children With Stroke: Polymorphism of the MTHFR Gene, Mild Hyperhomocysteinemia, and Vitamin Status , 2000, Journal of child neurology.

[67]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[68]  R. von Kries,et al.  Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey , 1999, European Journal of Pediatrics.

[69]  W. Kreuz,et al.  Prothrombotic risk factors in childhood stroke and venous thrombosis , 1999, European Journal of Pediatrics.

[70]  A. von Eckardstein,et al.  Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. , 1999, Blood.

[71]  R. Junker,et al.  Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood , 1999, European Journal of Pediatrics.

[72]  N. Akar,et al.  Factor V1691 G-A, Prothrombin 20210 G-A, and Methylenetetrahydrofolate Reductase 677 C-T Variants in Turkish Children With Cerebral Infarct , 1999, Journal of child neurology.

[73]  R. Junker,et al.  Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[74]  A. von Eckardstein,et al.  Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. , 1999, Circulation.

[75]  M. Bonduel,et al.  Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. , 1999, Archives of neurology.

[76]  E. Chalmers,et al.  Factor V Leiden, Prothrombin 20210 G → A and the MTHFR C677T Mutations in Childhood Stroke , 1999, Thrombosis and Haemostasis.

[77]  H. Blom,et al.  Hyperhomocysteinemia: a risk factor for ischemic stroke in children. , 1999, Circulation.

[78]  M. Behari,et al.  Activated protein C (APC) resistance in young stroke patients. , 1999, Thrombosis and haemostasis.

[79]  F. Cameron,et al.  Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum , 1999, European Journal of Pediatrics.

[80]  G. deVeber,et al.  Prothrombotic disorders in infants and children with cerebral thromboembolism. , 1998, Archives of neurology.

[81]  H. Hollema,et al.  Homozygous arginine-72 in wild type p53 and risk of cervical cancer , 1998, The Lancet.

[82]  W. Kreuz,et al.  Thrombophilic disorders in children with cerebral infarction , 1998, The Lancet.

[83]  F. Paky,et al.  Factor V Leiden and Prothrombin Gene G 20210 A Variant in Children with Ischemic Stroke , 1998, Thrombosis and Haemostasis.

[84]  A. Gürgey,et al.  Prothrombin gene 20210 G‐A mutation in Turkish patients with thrombosis , 1998, American journal of hematology.

[85]  F. Kirkham,et al.  Inherited prothrombotic states and ischaemic stroke in childhood , 1998, Journal of neurology, neurosurgery, and psychiatry.

[86]  U. Nowak‐Göttl,et al.  Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia , 1998, European Journal of Pediatrics.

[87]  P. Reitsma,et al.  Geographic Distribution of the 20210 G to A Prothrombin Variant , 1998, Thrombosis and Haemostasis.

[88]  S. Koh,et al.  Protein C and S deficiency in children with ischemic cerebrovascular accident. , 1997, Pediatric neurology.

[89]  A. Gürgey,et al.  The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey. , 1997, The Turkish journal of pediatrics.

[90]  B. Giusti,et al.  Prevalence of Factor V Leiden Mutation in Non-European Populations , 1997, Thrombosis and Haemostasis.

[91]  D. Rees.  The Population Genetics of Factor V Leiden (Arg506Gln) , 1996, British journal of haematology.

[92]  R. Kekomäki,et al.  Physiological anticoagulants and activated protein C resistance in childhood stroke , 1996, Acta paediatrica.

[93]  C. R. Kennedy,et al.  PROTEIN C DEFICIENCY AND STROKE IN EARLY LIFE , 1995, Developmental medicine and child neurology.

[94]  高井 俊夫.  奇形・脳性麻痺の起因に関するprospective follow up studyについて , 1966 .

[95]  S. Tanchou,et al.  Medical Statistics , 1838, Nature.

[96]  N. Modiano.  The Children. , 1898 .